$500M
Revenue target post-acquisition
Industry: Life Sciences
Service: Manufacturing
Service: Operations Strategy and Transformation
Service: Procurement
Service: Supply Chain
Service: Transactions and Turnaround
A publicly traded Point-of-Care molecular diagnostic device manufacturer specializing in rapid diagnostic tests for cardiometabolic diseases, infectious diseases, and toxicology.
$500M
Revenue target post-acquisition
$18M
Targeted cost synergies by end of 2019
Following the acquisition, the client faced operational, supply chain, and integration challenges that threatened value capture and efficiency.
EFESO’s structured integration approach delivered measurable operational, financial, and strategic outcomes for the client.
$11M
EBITDA improvement via operational enhancements
$13M
Cash flow improvement through supply chain and logistics optimization
$3M
Annual savings from warehouse consolidation
EFESO conducted a five-week deep-dive assessment followed by an eight-month structured implementation plan to integrate operations and supply chain post-acquisition.
Key initiatives included: